Selective laser trabeculoplasty (SLT) as replacement therapy in glaucoma patients
Completed
- Conditions
- many local and systemic side effects of anti glaucoma eye drops can be eliminated by using laser and reducing eye drops
- Registration Number
- NL-OMON22263
- Lead Sponsor
- none
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 145
Inclusion Criteria
patients with ocular hypertension or chronic open angle glaucoma controlled by medical therapy. Patients had to be prepared to sign an informed consent document.
Exclusion Criteria
other types of glaucoma than open angle glaucoma, previous trabeculectomy or selective laser trabeculoplasty. Corneal disease that inhibit good visualization of the trabecular meshwork and patients taking systemic steroids are excluded
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1, IOP lowering effect of SLT<br>
- Secondary Outcome Measures
Name Time Method 1, inflammatory parameters after SLT ( redness, pain, cells in anterior chamber, IOP spike)<br /><br>2, quality of life parameters